Hyris T-Cell Test finally allows healthcare specialists to depict SARS-CoV-2 specific immunity
Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS-CoV-2
05 août 2022 08h00 HE | Hyris
LONDON, Aug. 05, 2022 (GLOBE NEWSWIRE) -- As the pandemic crisis has entered a new phase, it is a common belief among the scientific community that COVID-19 is here to stay, maybe for a long time....
Hyris keeps supporting T cells Research
A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity
15 juin 2022 08h00 HE | Hyris
LONDON, June 15, 2022 (GLOBE NEWSWIRE) -- With over 460 million global cases thus far, 6 million of which have resulted in death, the COVID-19 pandemic from SARS-CoV-2 proved to be a dire health...
Hyris presents its disruptive T-Cells test to detect the body's immune response to SARS-CoV-2.
Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference 'A-Wish'
15 déc. 2021 12h00 HE | Hyris
LONDON, Dec. 15, 2021 (GLOBE NEWSWIRE) -- As the COVID-19 pandemic keeps causing concerns, with new variants spreading worldwide, it is now widely recognized that we must move beyond a...
Hyris Test quickly detects T-Cell response to SARSCoV2.
Hyris Chalk Up Another Success Fighting COVID19, Providing Canadian Researchers and Medical Specialists With a New Test to Detect T-Cell Immune Response to SARS-CoV-2
26 oct. 2021 08h00 HE | Hyris
OTTAWA, Ontario, Oct. 26, 2021 (GLOBE NEWSWIRE) -- After more than one year supporting the Canadian government, NGOs, and corporations in the fight against COVID-19, following the authorization...
Hyris supports research over COVID-19 Immunity
Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body's T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore's Duke-NUS Medical
14 oct. 2021 07h50 HE | Hyris
LONDON, Oct. 14, 2021 (GLOBE NEWSWIRE) -- After almost two years of fight against COVID-19, governments, NGOs, and corporations are now focusing on strategies and solutions to boost population...
Hyris supports research over COVID-19 Immunity
Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body's T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore's Duke-NUS Medical
14 oct. 2021 04h00 HE | Hyris
LONDON, Oct. 14, 2021 (GLOBE NEWSWIRE) -- After almost two years of fight against COVID-19, governments, NGOs, and corporations are now focusing on strategies and solutions to boost population...
Hyris System™ for Covid-19 diagnostics
The Hyris System™ Detects SARS-CoV-2, Including Recently Emerged Variants of Concerns.
14 sept. 2021 04h00 HE | Hyris
LONDON, England, Sept. 14, 2021 (GLOBE NEWSWIRE) -- New mutations of SARS-CoV-2 worldwide are causing several concerns regarding further disruption of public safety. Authorities involved in the...
Hyris-Logo-def.jpg
Hyris Brings Its Coronavirus Environmental Testing Kit to U.S.
21 mai 2020 09h00 HE | Hyris
LONDON, May 21, 2020 (GLOBE NEWSWIRE) -- Hyris, a leader in artificial intelligence (AI) applications for advanced diagnostics and creator of the bCUBE – a revolutionary portable DNA analysis...